BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND MSH2, COCA1, 4436, ENSG00000095002, HNPCC, FCC1, HNPCC1, P43246 AND Treatment
329 results:

  • 1. [Expression of immune checkpoints PD-L1, CTLA4, LAG3 in the microenvironment of colon adenocarcinoma depending on MMR status].
    Naumov SS; Krakhmal NV; Tashireva LA; Vtorushin SV
    Arkh Patol; 2024; 86(2):6-13. PubMed ID: 38591901
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Epigenetic MLH1 silencing concurs with mismatch repair deficiency in sporadic, naturally occurring colorectal cancer in rhesus macaques.
    Deycmar S; Johnson BJ; Ray K; Schaaf GW; Ryan DP; Cullin C; Dozier BL; Ferguson B; Bimber BN; Olson JD; Caudell DL; Whitlow CT; Solingapuram Sai KK; Romero EC; Villinger FJ; Burgos AG; Ainsworth HC; Miller LD; Hawkins GA; Chou JW; Gomes B; Hettich M; Ceppi M; Charo J; Cline JM
    J Transl Med; 2024 Mar; 22(1):292. PubMed ID: 38504345
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Cold atmospheric plasma stabilizes mismatch repair for effective, uniform treatment of diverse colorectal cancer cell types.
    He Y; Lu F; Jiang C; Gong F; Wu Z; Ostrikov K
    Sci Rep; 2024 Feb; 14(1):3599. PubMed ID: 38351129
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Association of a novel frameshift variant and a known deleterious variant in MMR genes with Lynch syndrome in Chinese families.
    Li J; Ni H; Wang X; Cheng W; Li L; Cheng Y; Liu C; Li Y; Deng A
    World J Surg Oncol; 2024 Jan; 22(1):36. PubMed ID: 38280988
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [A Case of Transverse Colon cancer Associated with Lynch Syndrome with Excellent Response to Pembrolizumab].
    Mori Y; Chika N; Suzuki O; Matsuyama T; Ito T; Muta Y; Chiyonobu N; Hatano S; Momose S; Tanabe N; Akagi K; Ishida H
    Gan To Kagaku Ryoho; 2023 Oct; 50(10):1111-1113. PubMed ID: 38035847
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Metastasis of endometrial adenocarcinoma masquerading as a primary rectal cancer: A rare case report with literature review.
    Li M; Zheng W
    Medicine (Baltimore); 2023 Nov; 102(46):e36170. PubMed ID: 37986305
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A locally advanced colon cancer patient with Muir-Torre syndrome obtains durable response to neoadjuvant and adjuvant immunotherapy.
    Guo Z; Cai Y; Yin W; Huang J
    Tumori; 2023 Dec; 109(6):NP27-NP31. PubMed ID: 37880978
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Applicability of the FDA-approved Immunohistochemical Panel for Identification of MMRd Phenotype in Uterine Endometrioid Carcinoma.
    Adachi S; Kimata JI; Hanami K; Adachi K; Igarashi T; Liang SG; Ishida Y; Fujino T; Yamazaki K
    Appl Immunohistochem Mol Morphol; 2024 Jan; 32(1):24-31. PubMed ID: 37859432
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Phase II Trial of Nivolumab in Metastatic Rare cancer with dMMR or MSI-H and Relation with Immune Phenotypic Analysis (the ROCK Trial).
    Okuma HS; Watanabe K; Tsuchihashi K; Machida R; Sadachi R; Hirakawa A; Ariyama H; Kanai M; Kamikura M; Anjo K; Hiramitsu A; Sekine S; Okita N; Mano H; Nishikawa H; Nakamura K; Yonemori K
    Clin Cancer Res; 2023 Dec; 29(24):5079-5086. PubMed ID: 37819940
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Glioma arising in the setting of mismatch repair deficiency-rare or are we missing it?
    Goyal A; Rao S; Rishi KS; Ramaswamy V; Sadashiva N; Santosh V
    Childs Nerv Syst; 2024 Jan; 40(1):233-237. PubMed ID: 37733272
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Rechallenge With Switching Immune Checkpoint Inhibitors Following Autoimmune Myocarditis in a Patient With Lynch Syndrome.
    Eslinger C; Walden D; Barry T; Shah S; Samadder NJ; Bekaii-Saab TS
    J Natl Compr Canc Netw; 2023 Sep; 21(9):894-899. PubMed ID: 37673116
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Constitutional Mismatch Repair Deficiency Syndrome as a Cause of Numerous Malignancies in a Teenage Patient-A Case Report.
    Samborska M; Galli D; Achkar R; Thambyrajah S; Derwich K
    J Pediatr Hematol Oncol; 2023 Oct; 45(7):e917-e920. PubMed ID: 37526375
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Advances in vaccine development for cancer prevention and treatment in Lynch Syndrome.
    Bolivar AM; Duzagac F; Sinha KM; Vilar E
    Mol Aspects Med; 2023 Oct; 93():101204. PubMed ID: 37478804
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Uncommon variants detected via hereditary cancer panel and suggestions for genetic counseling.
    Özdemir Z; Çevik E; Öksüzoğlu ÖBÇ; Doğan M; Ateş Ö; Esin E; Bilgetekin İ; Demirci U; Köseoğlu Ç; Topal A; Karadurmuş N; Erdem HB; Bahsi T
    Mutat Res; 2023; 827():111831. PubMed ID: 37453313
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Mismatch Repair Deficiency and Lynch Syndrome Among Adult Patients With Glioma.
    Benusiglio PR; Elder F; Touat M; Perrier A; Sanson M; Colas C; Guerrini-Rousseau L; Tran DT; Trabelsi N; Carpentier C; Marie Y; Adam C; Bernier M; Cazals-Hatem D; Mokhtari K; Tran S; Mathon B; Capelle L; Dhooge M; Idbaih A; Alentorn A; Houillier C; Dehais C; Hoang-Xuan K; Cuzzubbo S; Carpentier A; Duval A; Coulet F; Bielle F
    JCO Precis Oncol; 2023 May; 7():e2200525. PubMed ID: 37262394
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Germline drivers of gynecologic carcinosarcomas.
    Sia TY; Gordhandas SB; Birsoy O; Kemel Y; Maio A; Salo-Mullen E; Sheehan M; Hensley ML; Rubinstein M; Makker V; Grisham RN; O'Cearbhaill RE; Roche KL; Mueller JJ; Leitao MM; Sonoda Y; Chi DS; Abu-Rustum NR; Berger MF; Ellenson LH; Latham A; Stadler Z; Offit K; Aghajanian C; Weigelt B; Mandelker D; Liu YL
    Gynecol Oncol; 2023 Jul; 174():34-41. PubMed ID: 37149903
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Mismatch repair-deficient glioma with spatially distinct IDH-mutant and IDH-wild type components arising in the setting of Lynch syndrome.
    Tan H; Nerison C; Stateler C; Bowden SG; Raslan AM; Ambady P; Barajas RF; Wood MD
    Cold Spring Harb Mol Case Stud; 2023 Apr; 9(2):. PubMed ID: 37076313
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Surgical strategies for hereditary colorectal cancer].
    Kelm M; Wiegering A; Germer CT; Flemming S
    Chirurgie (Heidelb); 2023 May; 94(5):412-416. PubMed ID: 36856815
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Relation between mismatch repair status, chemoresponse, survival and anatomic location in gastroesophageal adenocarcinoma.
    Evaristo G; Katz A; Ramírez-GarcíaLuna JL; Issac MSM; Sangwan V; Thai DV; Bertos N; Guiot MC; Camilleri-Broët S; Marcus V; Mueller C; Cools-Lartigue J; Fiset PO; Ferri LE
    Can J Surg; 2023; 66(1):E79-E87. PubMed ID: 36792128
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The association of blood ctDNA levels to mutations of marker genes in colorectal cancer.
    Bai F; Du Q; Zou Q; Xu L; Dong W; Lv X; Han X; Zhou H; Zhang C; Lu T
    Cancer Rep (Hoboken); 2023 Apr; 6(4):e1782. PubMed ID: 36746394
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 17.